Tag: tyrosine kinase inhibitor kids

Home / tyrosine kinase inhibitor kids

Categories

Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia

Nov 2023: For paediatric patients aged one year and above with chronic phase (CP) Ph+ chronic myelogenous leukaemia (CML), either newly diagnosed (ND) or resistant or intolerant (R/I) to previous the...
tyrosine-kinase-inhibitor-kids

Scan the code